207 related articles for article (PubMed ID: 21712537)
21. Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients.
Schelpe AS; Roose E; Joly BS; Pareyn I; Mancini I; Biganzoli M; Deckmyn H; Voorberg J; Fijnheer R; Peyvandi F; De Meyer SF; Coppo P; Veyradier A; Vanhoorelbeke K
Haematologica; 2019 Jun; 104(6):1268-1276. PubMed ID: 30523052
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases.
Matsuyama T; Kuwana M; Matsumoto M; Isonishi A; Inokuma S; Fujimura Y
Thromb Haemost; 2009 Aug; 102(2):371-8. PubMed ID: 19652889
[TBL] [Abstract][Full Text] [Related]
23. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M
Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555
[TBL] [Abstract][Full Text] [Related]
24. Acquired TTP: ADAMTS13 meets the immune system.
Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.
Froehlich-Zahnd R; George JN; Vesely SK; Terrell DR; Aboulfatova K; Dong JF; Luken BM; Voorberg J; Budde U; Sulzer I; Lämmle B; Kremer Hovinga JA
Haematologica; 2012 Feb; 97(2):297-303. PubMed ID: 21993669
[TBL] [Abstract][Full Text] [Related]
26. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro.
Ostertag EM; Kacir S; Thiboutot M; Gulendran G; Zheng XL; Cines DB; Siegel DL
Transfusion; 2016 Jul; 56(7):1763-74. PubMed ID: 27040144
[TBL] [Abstract][Full Text] [Related]
27. Unraveling the immunologic response in thrombotic thrombocytopenic purpura.
Knöbl P
J Thromb Haemost; 2006 Nov; 4(11):2352-4. PubMed ID: 16938122
[No Abstract] [Full Text] [Related]
28. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
29. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
Lämmle B; Kremer Hovinga JA; George JN
Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
[No Abstract] [Full Text] [Related]
30. Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura.
Kangro K; Roose E; Joly BS; Sinkovits G; Falter T; von Auer C; Rossmann H; Reti M; Voorberg J; Prohászka Z; Lämmle B; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K
Blood Adv; 2021 Sep; 5(17):3427-3435. PubMed ID: 34495312
[TBL] [Abstract][Full Text] [Related]
31. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
32. Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP.
De Waele L; Curie A; Kangro K; Tellier E; Kaplanski G; Männik A; Tersteeg C; Joly BS; Coppo P; Veyradier A; De Meyer SF; Roose E; Vanhoorelbeke K
Blood Adv; 2021 Nov; 5(21):4480-4484. PubMed ID: 34559219
[TBL] [Abstract][Full Text] [Related]
33. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome.
Casina VC; Hu W; Mao JH; Lu RN; Hanby HA; Pickens B; Kan ZY; Lim WK; Mayne L; Ostertag EM; Kacir S; Siegel DL; Englander SW; Zheng XL
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9620-5. PubMed ID: 26203127
[TBL] [Abstract][Full Text] [Related]
34. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
[TBL] [Abstract][Full Text] [Related]
35. Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.
Quintero V; Garcia-Pose A; Barrios-Tascon A; Pacheco-Cumani M
J Pediatr Hematol Oncol; 2014 Nov; 36(8):653-5. PubMed ID: 24942015
[TBL] [Abstract][Full Text] [Related]
36. Generation and validation of small ADAMTS13 fragments for epitope mapping of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura.
Kangro K; Roose E; Schelpe AS; Tellier E; Kaplanski G; Voorberg J; De Meyer SF; Männik A; Vanhoorelbeke K
Res Pract Thromb Haemost; 2020 Jul; 4(5):918-930. PubMed ID: 32685903
[TBL] [Abstract][Full Text] [Related]
37. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
Starke R; Machin S; Scully M; Purdy G; Mackie I
Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
[TBL] [Abstract][Full Text] [Related]
38. Conformational activation of ADAMTS13.
South K; Luken BM; Crawley JT; Phillips R; Thomas M; Collins RF; Deforche L; Vanhoorelbeke K; Lane DA
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18578-83. PubMed ID: 25512499
[TBL] [Abstract][Full Text] [Related]
39. Analysis on the molecular species and concentration of circulating ADAMTS13 in Blood.
Soejima K; Nakamura H; Hirashima M; Morikawa W; Nozaki C; Nakagaki T
J Biochem; 2006 Jan; 139(1):147-54. PubMed ID: 16428330
[TBL] [Abstract][Full Text] [Related]
40. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Lämmle B
Hematology Am Soc Hematol Educ Program; 2012; 2012():610-6. PubMed ID: 23233642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
